OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Kelly D. Moynihan, Manu P. Kumar, Hussein Sultan, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1206-1225
Open Access | Times Cited: 13
Kelly D. Moynihan, Manu P. Kumar, Hussein Sultan, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1206-1225
Open Access | Times Cited: 13
Showing 13 citing articles:
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P. Ward, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 182-191
Open Access | Times Cited: 16
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P. Ward, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 182-191
Open Access | Times Cited: 16
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 8
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 8
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1226-1251
Open Access | Times Cited: 5
Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1226-1251
Open Access | Times Cited: 5
Engineering cytokines for tumor-targeting and selective T cell activation
Kun Peng, Yang‐Xin Fu, Yong Liang
Trends in Molecular Medicine (2025)
Closed Access
Kun Peng, Yang‐Xin Fu, Yong Liang
Trends in Molecular Medicine (2025)
Closed Access
Orchestration of immunoregulatory signaling ligand and receptor dynamics by mRNA modifications: Implications for therapeutic potential
Zizhao Mai, Xu Chen, Ye Lu, et al.
International Journal of Biological Macromolecules (2025), pp. 142987-142987
Closed Access
Zizhao Mai, Xu Chen, Ye Lu, et al.
International Journal of Biological Macromolecules (2025), pp. 142987-142987
Closed Access
Immunotherapy for Renal Cell Carcinoma—What More is to Come?
Zachary A. Yochum, David A. Braun
Targeted Oncology (2025)
Closed Access
Zachary A. Yochum, David A. Braun
Targeted Oncology (2025)
Closed Access
Glucose Metabolism‐Targeted Poly(amino acid) Nanoformulation of Oxaliplatin(IV)‐Aspirin Prodrug for Enhanced Chemo‐Immunotherapy
Jiazhen Yang, Tianqi Su, Qinqi Wang, et al.
Advanced Materials (2025)
Closed Access
Jiazhen Yang, Tianqi Su, Qinqi Wang, et al.
Advanced Materials (2025)
Closed Access
Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8+T cells
Kayoung Shin, Min Park, Seoho Kim, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e008594-e008594
Open Access
Kayoung Shin, Min Park, Seoho Kim, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e008594-e008594
Open Access
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 3
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 3
Targeted Bias: The Next Swing at IL2 Therapy
Kayla Kulhanek, Anusha Kalbasi
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1145-1146
Closed Access | Times Cited: 1
Kayla Kulhanek, Anusha Kalbasi
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1145-1146
Closed Access | Times Cited: 1
Synaptic synergy of T cell receptor and interleukin 2 receptor in CD8+T cells
Jesusa Capera, Ashwin Jainarayanan, Salvatore Valvo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Jesusa Capera, Ashwin Jainarayanan, Salvatore Valvo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer
R. Salvador, B.F.C. Correia, D.S.C.P. Grosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
R. Salvador, B.F.C. Correia, D.S.C.P. Grosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Exploring the Therapeutic Potential of Triterpenoid Saponins from Gymnema sylvestre: Mechanistic Insights into Hepatoprotection, Immunomodulation, Anticancer Activities, Molecular Docking, and Pharmacokinetics
Vasudeva Reddy Netala, Tianyu Hou, Rajakumari Devarapogu, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40850-e40850
Open Access
Vasudeva Reddy Netala, Tianyu Hou, Rajakumari Devarapogu, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40850-e40850
Open Access
Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapy
Peng Liu, Liwei Zhao, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Peng Liu, Liwei Zhao, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Targeting ACAT1 for Precision Chemo‐Immunoprevention in Lung Cancer
Mofei Huang, Jing Pan, Shizuko Sei, et al.
Advanced Therapeutics (2024)
Closed Access
Mofei Huang, Jing Pan, Shizuko Sei, et al.
Advanced Therapeutics (2024)
Closed Access
